id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-D-1862-0007,FDA,FDA-2014-D-1862,Recommended Warning for Over-the-Counter Acetaminophen-Containing Drug Products and Labeling Statements Regarding Serious Skin Reactions; Guidance for Industry; Availability,Notice,Notice of Availability,2017-01-11T05:00:00Z,2017,1,2017-01-11T05:00:00Z,,2017-01-11T15:36:55Z,2017-00375,0,0,090000648245b076
FDA-2014-D-1862-0008,FDA,FDA-2014-D-1862,Recommended Warning for Over-the-Counter Acetaminophen-Containing Drug Products and Labeling Statements Regarding Serious Skin Reactions; Guidance for Industry,Other,Guidance,2017-01-11T05:00:00Z,2017,1,2017-01-11T05:00:00Z,,2024-11-12T06:17:57Z,,1,0,090000648245ba06
FDA-2014-D-1862-0002,FDA,FDA-2014-D-1862,Recommended Warning for Over-the-Counter Acetaminophen-Containing Drug Products and Labeling Statements Regarding Serious Skin Reactions,Other,Guidance,2014-11-28T05:00:00Z,2014,11,2014-11-28T05:00:00Z,,2019-06-18T15:46:55Z,,0,0,090000648194ac98
FDA-2014-D-1862-0001,FDA,FDA-2014-D-1862,Recommended Warning for Over-the-Counter Acetaminophen-Containing Drug Products and Labeling Statements Regarding Serious Skin Reactions; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2014-11-28T05:00:00Z,2014,11,2014-11-28T05:00:00Z,2015-01-28T04:59:59Z,2015-01-28T03:22:04Z,2014-28086,0,0,090000648194b65d